天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID Struktur
1354379-54-6
CAS-Nr.
1354379-54-6
Englisch Name:
CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID
Synonyma:
CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID;Cyclohexanecarboxylic acid, 4-fluoro-,cis-
CBNumber:
CB83585575
Summenformel:
C7H11FO2
Molgewicht:
146.16
MOL-Datei:
1354379-54-6.mol

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID Eigenschaften

Siedepunkt:
248.8±33.0 °C(Predicted)
Dichte
1.15±0.1 g/cm3(Predicted)
pka
4?+-.0.25(Predicted)

Sicherheit

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID Chemische Eigenschaften,Einsatz,Produktion Methoden

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aceschem Inc. 		+1-817863-6948 +1-（817）863-6948
 sales@aceschem.com United States 19632 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323658 +86-18168183658
 sales1@artkmedchem.com China 39004 58
Aikon International Limited 025-66113011 18112977050
 sales01@aikonchem.com China 16027 58
Jiangsu yize medical technology co. LTD 18962082606
 3394205705@qq.com China 9842 58
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
 service@aiviche.com China 49312 58
Shanghai Ruipu Medical Technology Co., Ltd 15895968936
 1018762393@qq.com China 10000 58
Shanghai Jianchao Biotechnology Co., LTD 13621743886 13621743886
 3366408901@qq.com China 6681 58
Suzhou Haiben Pharmaceutical Co., Ltd 18012778619
 93743011@qq.com China 469 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
 marketing@pharmablock.com China 9126 58
  • CIS-4-FLUOROCYCLOHEXANECARBOXYLIC ACID
  • Cyclohexanecarboxylic acid, 4-fluoro-,cis-
  • 1354379-54-6
Copyright 2019 ? ChemicalBook. All rights reserved